Consulting Services for Drug Discovery and
Innovative Strategies from Lead Discovery to
Clinical Development Specializing in Small
provides innovative strategies to
biopharmaceutical organizations of all sizes from
established and fully integrated companies to
start-ups looking for proof of concept.
Founder Daniel E.
Levy received his Ph.D. in organic chemistry from
MIT and his B.S. degree from the University of
California - Berkeley. Since 1992, Dr. Levy
worked with companies in all capacities from
consultant to director. His broad experience
in drug discovery and development provides him a
unique perspective enabling him to address issues
at the interface of chemistry and biology long
before they impede progress.
Dr. Levy has strategies for addressing the most
challenging problems independent of therapeutic
area or biological target. With a strong
focus on PK/ADME, pre-formulation, toxicity and
scale-up issues, new paradigms for discovery
research are applied. Through early parallel
screening and incorporation of CRO activities, the
pathway to success is accelerated. With a
close eye on synthetic methods, cost of
manufacturing is reduced.
Copyright Daniel E. Levy, All